Novan, Inc.

Novan, Inc.verified

NOVN

Price:

$0.0941

Market Cap:

$2.64M

Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; W...[Read more]

Industry

Biotechnology

IPO Date

2016-09-21

Stock Exchange

NASDAQ

Ticker

NOVN

The Enterprise Value as of September 2024 (TTM) for Novan, Inc. (NOVN) is -6052751.00

According to Novan, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6052751.00. This represents a change of -121.21% compared to the average of 28.54M of the last 4 quarters.

Novan, Inc. (NOVN) Historical Enterprise Value (quarterly & annually)

How has NOVN Enterprise Value performed in the past?

The mean historical Enterprise Value of Novan, Inc. over the last ten years is 73.65M. The current -6052751.00 Enterprise Value has changed -921.85% with respect to the historical average. Over the past ten years (40 quarters), NOVN's Enterprise Value was at its highest in in the December 2016 quarter at 396.10M. The Enterprise Value was at its lowest in in the December 2015 quarter at -45678000.00.

Quarterly (TTM)
Annual

Average

73.65M

Median

55.18M

Minimum

-720000.00

Maximum

194.87M

Novan, Inc. (NOVN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novan, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 255.60%

Maximum Annual Enterprise Value = 194.87M

Minimum Annual Increase = -27164.97%

Minimum Annual Enterprise Value = -720000.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202223.76M-14.19%
202127.69M-39.01%
202045.41M-39.87%
201975.51M255.60%
201821.24M-67.30%
201764.95M-48.93%
2016127.17M-18.79%
2015156.59M-19.64%
2014194.87M-27164.97%

Novan, Inc. (NOVN) Average Enterprise Value

How has NOVN Enterprise Value performed in the past?

The current Enterprise Value of Novan, Inc. (NOVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

32.29M

5-year avg

38.72M

10-year avg

73.65M

Novan, Inc. (NOVN) Enterprise Value vs. Peers

How is NOVN’s Enterprise Value compared to its peers?

Novan, Inc.’s Enterprise Value is less than Tarsus Pharmaceuticals, Inc. (1.05B), greater than LianBio (-66141903.00), less than Aldeyra Therapeutics, Inc. (348.86M), less than Travere Therapeutics, Inc. (1.21B), less than Eton Pharmaceuticals, Inc. (105.77M), less than Tonix Pharmaceuticals Holding Corp. (8.24M), less than Jaguar Health, Inc. (28.36M), less than Acasti Pharma Inc. (5.04M), less than Diffusion Pharmaceuticals Inc. (-1447403.00), less than iBio, Inc. (26.47M), less than Aditxt, Inc. (9.63M), greater than Palisade Bio, Inc. (-6597681.00), less than Plus Therapeutics, Inc. (6.84M), greater than Revelation Biosciences, Inc. (-10643144.00), less than Quoin Pharmaceuticals, Ltd. (218.65K), less than Onconova Therapeutics, Inc. (4.51M), less than Adial Pharmaceuticals, Inc. (3.12M), greater than Aeterna Zentaris Inc. (-11767918.00), less than Lyra Therapeutics, Inc. (22.69M), less than Trevi Therapeutics, Inc. (202.38M), less than SQZ Biotechnologies Company (24.11M), greater than Protara Therapeutics, Inc. (-46328721.00), greater than TRACON Pharmaceuticals, Inc. (-6075428.00),

Build a custom stock screener for Novan, Inc. (NOVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novan, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novan, Inc. (NOVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novan, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Novan, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Novan, Inc. (NOVN)?

What is the 3-year average Enterprise Value for Novan, Inc. (NOVN)?

What is the 5-year average Enterprise Value for Novan, Inc. (NOVN)?

How does the current Enterprise Value for Novan, Inc. (NOVN) compare to its historical average?